Work With Us

Contracting Overview

The JPEO-CBRND’s mission to provide the best CBRN technology and equipment - at the right place - at the right time - at the right cost is possible only with participation from one of our key partners, Industry. In support of the Joint Forces, Industry plays a vital role in supporting our Nation's Defense.

JPEO-CBRND contracting office has two focus areas; Multiple Award Task Order Contract (MATOC) and Other Transaction Agreements (OTA).


COVID-19 Information for Industry Partners

Defense Industrial Base Essential Critical Infrastructure Workforce - Under Secretary of Defense for Acquisition and Sustainment, the Honorable Ellen Lord (March 20, 2020)

Promoting Resiliency of the Defense Industrial Base During the COVID-19 Pandemic - Assistant Secretary of the Army for Acquisition, Sustainment, and Technology, the Honorable Dr. Bruce Jette,  (March 24, 2020)


JPEO Contracting Strategy

Multiple Award Task Order Contract (MATOC)

MATOCs promote competition, save costs, encourage small business participation, minimize time to award and streamline documentation. The MATOCs are managed by the Omnibus Program Management Office; click here for contact information. And select below for information and opportunities in each contract area.


Other Transaction Agreements (OTAs)


OTAs are a very valuable tool to enable DoD to access technology that would otherwise not be possible.


JPM CBRN Medical TechWatch



JPM CBRN Medical plays a vital role in enhancing the U.S. Department of Defense’s strategy to prevent, diagnose and treat the effects of chemical, biological, radiological and nuclear (CBRN) threats and emerging infectious diseases. JPM CBRN Medical is instrumental in protecting civilian and military populations against injury and disease caused by naturally encountered infectious agents as well as intentional exposure related to CBRN warfare. Opportunities through a public-private partnership to help JPM CBRN Medical in the advanced development and acquisition of safe, effective and innovative medical solutions and systems to combat CBRN and other emerging infectious diseases.